Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Naltrexone for Chronic Pain in Arthritis
NCT03008590Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- May 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in osteoarthritis (OA), rheumatoid arthritis (RA), psoriatic arthritis (PsA), peripheral spondyloarthritis (pSpA), sponsored by VA Office of Research & Development. Started May 2018; status: completed.
02
Drugs
naltrexone
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)psoriatic arthritis (PsA)peripheral spondyloarthritis (pSpA)
Beyond the preview
Go deeper on NCT03008590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03008590.